Clodronate treatment influences MMP-2 associated outcome in node positive breast cancer

被引：0
|
作者：
S. Leppä
T. Saarto
L. Vehmanen
C. Blomqvist
I. Elomaa
机构：
[1] Helsinki University Central Hospital,Department of Oncology
[2] University of Helsinki,Molecular Cancer Biology Research Program, Biomedicum Helsinki
[3] University of Uppsala,Department of Oncolgy
来源：
Breast Cancer Research and Treatment | 2005年 / 90卷
关键词：
adjuvant; bisphosphonate; breast cancer; matrix metalloproteinase; prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Purpose. Serum postoperative matrix metalloproteinase 2 (MMP-2) level is a predictor of outcome in node positive breast cancer and can be used to stratify patients into low and high risk groups. Our aim was to determine how clodronate treatment influences MMP-2 associated clinical outcome.
引用
收藏
页码：117 / 125
页数：8
相关论文
共 50 条
  • [1] Clodronate treatment influences MMP-2 associated outcome in node positive breast cancer
    Leppä, S
    Saarto, T
    Vehmanen, L
    Blomqvist, C
    Elomaa, I
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 90 (02) : 117 - 125
  • [2] MMP-2 and MMP-9 in lymph node positive bladder cancer
    Fleischmann, A.
    Seiler, R.
    Thalmann, G. N.
    VIRCHOWS ARCHIV, 2011, 459 : S279 - S279
  • [3] MMP-2 and MMP-9 in lymph-node-positive bladder cancer
    Seiler, Roland
    Thalmann, George N.
    Fleischmann, Achim
    JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (12) : 1078 - 1082
  • [4] MMP-2 and MMP-9 in lymph-node-positive bladder cancer
    Hegarty, Paul K.
    JOURNAL OF CLINICAL PATHOLOGY, 2012, 65 (05) : 470 - 471
  • [5] Genetic prognostic index influences patient outcome for node-positive breast cancer
    Asaka, Shin-Ichi
    Fujimoto, Takashi
    Akaishi, Junko
    Ogawa, Kenji
    Onda, Masamitsu
    SURGERY TODAY, 2006, 36 (09) : 793 - 801
  • [6] Genetic Prognostic Index Influences Patient Outcome for Node-Positive Breast Cancer
    Shin-ichi Asaka
    Takashi Fujimoto
    Junko Akaishi
    Kenji Ogawa
    Masamitsu Onda
    Surgery Today, 2006, 36 : 793 - 801
  • [7] MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients
    Langers, A. M. J.
    Verspaget, H. W.
    Hawinkels, L. J. A. C.
    Kubben, F. J. G. M.
    van Duijn, W.
    van der Reijden, J. J.
    Hardwick, J. C. H.
    Hommes, D. W.
    Sier, C. F. M.
    BRITISH JOURNAL OF CANCER, 2012, 106 (09) : 1495 - 1498
  • [8] MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients
    A M J Langers
    H W Verspaget
    L J A C Hawinkels
    F J G M Kubben
    W van Duijn
    J J van der Reijden
    J C H Hardwick
    D W Hommes
    C F M Sier
    British Journal of Cancer, 2012, 106 : 1495 - 1498
  • [9] Doxorubicin conjugated with a trastuzumab epitope and an MMP-2 sensitive peptide linker for the treatment of HER2-positive breast cancer
    You, Yiwen
    Xu, Zhiyuan
    Chen, Yun
    DRUG DELIVERY, 2018, 25 (01) : 448 - 460
  • [10] Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer
    Langenskiöld, M
    Holmdahl, L
    Falk, P
    Ivarsson, ML
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2005, 20 (03) : 245 - 252
12345